Personalized Activity Intervention in Rehabilitation After Cardiac Operations (the PACO Trial)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-90
SponsorKuopio University Hospital

About this trial

The PACO trial is a randomized clinical trial conducted in Heart Centers of Kuopio and Turku university hospitals. The coronary artery disease, aortic valve stenosis and mitral valve insufficiency patients preparing for elective coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or mitral valve repair (MVR) will be randomized to either intervention or control group. The specific operation groups (CABG, AVR and MVR) will be analyzed separately. The 7-day baseline measurements of sedentary behaviour (SB), physical activity (PA) and sleep will be conducted to the patients by using the RM42 accelerometer during the pre-operative month.

After the cardiac procedure is completed and the patient is moved to post-operative ward, the control group patients will begin the standard post-operative rehabilitation program of the participating hospitals (activity guidance given by a physiotherapist). Patients in the intervention groups will follow the identical program but after discharge they will also receive personalized activity guidance through the combination of ExSed smart phone application, Suunto MoveSense accelerometer and cloud system during the first 90 days of post-operative rehabilitation. Weekly evolving daily goals to replace SB with PA (daily goals for steps, moderate PA, light PA and standing, and sitting time limit) will be designed for each patient of the intervention groups. A new daily step goal will be delivered from the cloud system to the patient's smart phone in the beginning of each week of the intervention. The daily step goal of the first intervention week is based on patient's walking distance assessed by a physiotherapist in post-operative ward. The following goals will be automatically evolved in the basis of patient's personal average step count of the previous week. The MoveSense accelerometer will measure accumulated levels of SB, PA and sleep, and transmit the data to user's ExSed application with Bluetooth. With information about accumulated levels of SB and PA, the application is able to guide the patient to accomplish the predefined activity goal. The guidance and motivation will be offered with pop-up notifications and histograms (columns are fulfilled according to patient's accumulated daily activity). The researches retain a remote access to the activity data of patients in the cloud system. The ExSed application will be connected to the cloud system with internet connection.

In addition, the patients of the intervention groups will receive short video files (lasting from 1 to 3 minutes) containing exercise guidance from a physiotherapist specialized to cardiac operation patients. These videos are available on the ExSed application during the intervention. The physiotherapist will also contact each patient (by mobile phone) with structured contact form from 1 to 4 times in a month to make sure that the intervention is proceeding as designed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

An eligible patient with coronary artery disease, aortic valve stenosis or mitral valve insufficiency scheduled for elective coronary artery bypass grafting, aortic valve replacement or mitral valve repair operation.

He / she does not have any severe disease or functional limitation limiting PA (other than CVD).

He / she is willing to wear a hip- and wrist-worn accelerometer.

He / she is willing and capable to use a smart phone application.

Disqualifiers

He / she ends up in prolonged intensive care after cardiac operation.

He / she has a memory disorder (i.e. Alzheimer's disease).

Trial design

Design model

Parallel

Treatments tested in this trial

  • PACO intervention for CABG patients

    Behavioral

    The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from coronary artery bypass grafting (CABG). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.

  • PACO intervention for AVR patients

    Behavioral

    The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from aortic valve replacement (AVR). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.

  • PACO intervention for MVR patients

    Behavioral

    The PACO intervention is based on post-operative guidance to replace prolonged SB with PA in the rehabilitation of patients recovering from mitral valve repair (MVR). The guidance will be provided to the patients with the combination of ExSed smart phone application, accelerometer and cloud system. In addition, exercise guidance (short video files) and regular mobile phone contacts from physiotherapist will be provided to the intervention patients.

Treatment groups

540 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: CABG control groupNo intervention 0 interventions
Group B: PACO intervention for CABG patientsExperimental treatment 1 intervention
Group C: AVR control groupNo intervention 0 interventions
Group D: PACO intervention for AVR patientsExperimental treatment 1 intervention
Group E: MVR control groupNo intervention 0 interventions
Group F: PACO intervention for MVR patientsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Improvement in mean daily number of steps

The improvement in mean daily number of steps after 3 months from discharge. In addition, the follow-up will be continued until 12 months after discharge. The baseline values of mean daily number of steps will be determined in a 7-day accelerometer measurements conducted to the patients before the elective cardiac operation. The mean daily number of steps after the first 3 and 12 months of post-operative rehabilitation at home will be also determined in 7-day (24 h) accelerometer measurements. The raw accelerometer data will be analyzed with Mean Amplitude Deviation and Angle for Posture Estimation -algorithms to recognize the daily steps for the 7 days of which average will be calculated for each study patient.

Time frame
Improvement between baseline (during the last preoperative month) and first 3 (and 12) months after discharge.

Secondary outcomes

1

Change in mean daily accumulated total time of light PA and MVPA

The post-operative change in patient's mean daily accumulated total time of light and moderate to vigorous physical activity.

Time frame
Change between baseline (during the last preoperative month) and first 3 months after discharge.
2

Change in mean daily total time of sedentary behaviour (SB)

The post-operative change in patient's mean daily total time of SB.

Time frame
Change between baseline (during the last preoperative month) and first 3 months after discharge.
3

Change in maximal oxygen consumption

The evolvement of patient's maximal oxygen consumption (VO2 peak) will be determined in 6 minute walking test, conducted to the patients twice (after 1 and 3 months) post-operatively. Only a part of the randomized patients coming from city areas of Kuopio and Turku will be included to the measurements of maximal oxygen consumption.

Time frame
Change between the first and third months after discharge.
4

Improvement in self-perceived quality of life (QoL) assessed with SAQ-7 -questionnaire

The improvement in patient's post-operative quality of life after 3 months of rehabilitation. The quality of life will be determined with Seattle Angina Questionnaire 7 (SAQ-7).

Time frame
Improvement between baseline (during the last preoperative month) and first 3 months after discharge.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kuopio University Hospital

Lead sponsor

UKK Institute

Collaborator

Turku University Hospital

Collaborator